Analysis of the prevalence of von Hippel-Lindau Syndrome in patients with hemangioblastomas of the Central Nervous System

Authors

DOI:

https://doi.org/10.33448/rsd-v11i2.26018

Keywords:

Hemangioblastoma; Von Hippel-Lindau syndrome; Prevalence.

Abstract

Hemangioblastomas (HBs) are benign neoplasms commonly located in the cerebellum and spinal cord and may arise sporadically or related to von Hippel-Lindau Syndrome (VHL). When there is an association with VHL, multifocal tumors may arise, unlike sporadic tumors, which are isolated. VHL is a hereditary disease related to the development of benign and malignant tumors, the most common being central nervous system hemangioblastomas and retinal angiomas. The disease is caused by the inefficacy of the Tumor Suppressor Gene VHL (pVHL) in an allolo on chromosome 3p25-26. The presence of VHL in patients with HBs leads the patient to a worse prognosis, as it facilitates metastatization. Thus, the aim of the following review is to analyze the prevalence of von Hippel-Lindau syndrome in patients with central nervous system (CNS) hemangioblastomas. This is a systematic bibliographic review that used the PubMed, SciELO and Google Scholar platforms as databases for research of scientific articles, with a time frame between 2016 and 2022, in English. According to the search engine, 4 results were found after the exclusion criteria in the PubMed and Google Scholar databases. It was found, therefore, that there is a moderate prevalence of HLV in patients with CNS HBs. Among the studies, the lowest prevalence rate of HlV in patients with HBs was 23%, while the highest rate was approximately 60%, with an overall average of ± 39.2%, when considering all studies involving these patients.

References

Ammerman, J. M., Lonser, R. R., Dambrosia, J., Butman, J. A., & Oldfield, E. H. (2006). Long-term natural history of hemangioblastomas in patients with von Hippel–Lindau disease: implications for treatment. Journal of neurosurgery, 105(2), 248-255.

Cervio, A., Villalonga, J. F., Liñares, J. M., Mormandi, R., Condomí Alcorta, S., & Salvat, J. (2015). Tratamiento quirúrgico de los hemangioblastomas del sistema nervioso central. Rev Argent Neuroc, 29(3), 117-131.

Cheng, J., Liu, W., Zhang, S., Lei, D., & Hui, X. (2017). Clinical features and surgical outcomes in patients with cerebellopontine angle hemangioblastomas: retrospective series of 23 cases. World neurosurgery, 103, 248-256.

Chittiboina, P., & Lonser, R. R. (2015). Doença de Von Hippel-Lindau. Manual de neurologia clínica, 132, 139–156. https://doi.org/10.1016/B978-0-444-62702-5.00010-X

Findeis-Hosey, J. J., McMahon, K. Q., & Findeis, S. K. (2016). Von hippel–lindau disease. Journal of Pediatric Genetics, 5(02), 116-123.

Frantzen, C., Links, T. P., & Giles, R. H. (2012). von Hippel-Lindau disease. GeneReviews. Seattle (WA): University of Washington, Seattle.

Guerrero-Galindo, R., Castrejón, E., Aguirre-Portillo, L., Cervantes-Michel, J. L., & Espejo-Plascencia, I. (2012). Intramedullary hemangioblastoma. Archivos de Neurociencias, 17(4), 247-249.

Kanno, H., Kobayashi, N., & Nakanowatari, S. (2014). Pathological and Clinical Features and Management of Central Nervous System Hemangioblastomas in von Hippel-Lindau Disease. Journal of kidney cancer and VHL, 1(4), 46–55. https://doi.org/10.15586/jkcvhl.2014.12

Koo, H. W., Park, J. E., Cha, J., Kim, D. J., Kang, S. G., Lim, S. C., & Suh, D. C. (2016). Hemangioblastomas with leptomeningeal dissemination: Case series and review of the literature. Acta neurochirurgica, 158(6), 1169-1178.

Lonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003). von Hippel-Lindau disease. The Lancet, 361(9374), 2059-2067.

Maher, E. R., Neumann, H. P., & Richard, S. (2011). von Hippel–Lindau disease: A clinical and scientific review. European Journal of Human Genetics, 19(6), 617-623.

Malleo, G. (2010). Pancreatic cystic tumours: when to resect, when to observe. European review for medical and pharmacological sciences, 14, 395-406.

Nordstrom‐O'Brien, M., van der Luijt, R. B., van Rooijen, E., van den Ouweland, A. M., Majoor‐Krakauer, D. F., Lolkema, M. P., ... & Giles, R. H. (2010). Genetic analysis of von Hippel‐Lindau disease. Human mutation, 31(5), 521-537.

Patel, N. P., Robinson, T. M., Lesley, W. S., Garrett, D., Shan, Y., & Huang, J. H. (2019). Hemangioblastoma Retromedular Imitando um Aneurisma da Artéria Cerebelar Inferior Posterior: Relato de Caso e Revisão de Literatura. Neurocirurgia Mundial, 122, 165–170. https://doi.org/10.1016/j.wneu.2018.10.188

Pavesi, G., Feletti, A., Berlucchi, S., Opocher, G., Martella, M., Murgia, A., & Scienza, R. (2008). Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas: benefits, risks and outcome. Journal of neurosurgical sciences, 52(2), 29-36.

Sampaio, D. B., Lima, W. P. de, Matias, I. de S., Saraiva, I. S., Ferreira, M. L., Ramos, V. M., & Ribeiro, P. J. T. (2022). Treatment of hemangiomas in the head and neck region: integrative literature review. Research, Society and Development, 11(1), e43811125236. https://doi.org/10.33448/rsd-v11i1.25236

Seizinger, B. R., Rouleau, G. A., Ozelius, L. J., Lane, A. H., Farmer, G. E., Lamiell, J. M., ... & Gusella, J. F. (1988). Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature, 332(6161), 268-269.

Wanebo, J. E., Lonser, R. R., Glenn, G. M., & Oldfield, E. H. (2003). The natural history of hemangioblastomas of the central nervous system in patients with von Hippel—Lindau disease. Journal of neurosurgery, 98(1), 82-94.

Wang, Q., Meng, S., Cheng, J., Zhang, S., Ju, Y., Fang, Y., ... & Hui, X. (2020). Central nervous system hemangioblastomas: An age-stratified analysis. Clinical Neurology and Neurosurgery, 199, 106281.

Westwick, H. J., Giguère, J. F., & Shamji, M. F. (2016). Incidence and prognosis of spinal hemangioblastoma: a surveillance epidemiology and end results study. Neuroepidemiology, 46(1), 14-23.

Published

03/02/2022

How to Cite

FONSECA, G. S. G. B. .; FREIRE, V. M. L. M. .; BONFIM, L. L.; PENHA, E. C. da S. .; GUIMARÃES, J. V. A. .; PEREIRA, R. E. L. .; MACEDO, G. de S. .; BRITTO, F. A. L. C. de .; MURAD, L. M. de A. .; BRITO, A. do R. .; REIS, L. L. T. .; SANTOS, A. C. .; MESQUITA NETO, A. R. .; PRAZERES, J. S. .; CUNHA, L. M. B. L. .; MAIA, A. V. F. B. .; SILVA, C. W. da .; BORGES, F. de A. .; ALMEIDA, M. B. de .; VIEIRA, S. C. .; SOARES, I. C. B. .; TAPETY SÁ, L.; PEREIRA, L. A.; BEZERRA, T. M. .; SOARES, I. M. .; SOUSA, R. M. C. .; COELHO, M. B. C. .; CALDEIRA, F. R. . Analysis of the prevalence of von Hippel-Lindau Syndrome in patients with hemangioblastomas of the Central Nervous System. Research, Society and Development, [S. l.], v. 11, n. 2, p. e44311226018, 2022. DOI: 10.33448/rsd-v11i2.26018. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/26018. Acesso em: 20 feb. 2024.

Issue

Section

Health Sciences